B2.jpg b2_ph.jpg
  • Dayao ZHAO M.D., Ph.D.

    Chief Executive Officer

    AffaMed Therapeutics

  • Ji LI Ph.D.

    President, Chief Strategy Officer & Director

    AffaMed Therapeutics

  • Vijay P. Karwal M.Sc., CFA

    Chief Financial Officer

    AffaMed Therapeutics

  • Cen XU Ph.D.

    Chief Scientific Officer

    AffaMed Therapeutics

  • Minji Kim PhD, MBA

    General Manager, AffaMed Digital

  • Rose YU M.D., MSc & EMBA

    Chief Regulatory Officer

    AffaMed Therapeutics

  • Yi HAN Ph.D.

    General Manager, AffaMed Technologies

    VP, Strategy and PPM, AffaMed Therapeutics


Mengjiao JIANG

Managing Director

Ms. Jiang has over 17 years of investment, merger and acquisition and investment banking experience. She is Managing Director of CBC Group, a healthcare-dedicated private equity firm, and has served as a Partner and a Managing Director since January 2014. Ms. Jiang currently also serves on the board of several private companies.

Ms. Jiang served as Director and COO at Far East Horizon’s Investments Group, a financial services organization, from March 2012 to December 2013. Prior to that, Ms. Jiang served at ARC China Inc. as Managing Director, as well as Associate Director at BDA, a cross border M&A firm, and UBS Investment Bank in New York.

Ms. Jiang received her bachelor’s degree in Economics with a Political Science double major from Wellesley College in Massachusetts in May 2003